Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros

País/Región como asunto
Intervalo de año de publicación
1.
HU rev ; 48: 1-11, 2022.
Artículo en Portugués | LILACS | ID: biblio-1379026

RESUMEN

Introdução: A síndrome do piriforme (SP) é uma causa de dor ciática pouco entendida e conhecida, por isso, subdiagnosticada. Possui múltiplas possibilidades etiológicas e a abordagem terapêutica corrente privilegia o tratamento conservador. Objetivo: Neste estudo retrospectivo são destacados o diagnóstico, a etiologia, o diagnóstico diferencial e analisados os resultados do tratamento instituído. Métodos: 34 casos com seguimento mínimo de seis meses e máximo de 12 meses avaliados por uma escala simplificada de graduação de sintomas. Resultados: O tratamento clínico-conservador obteve excelentes resultados em 23 pacientes (67,6%), bom em nove pacientes (26,4%) e razoáveis (insatisfatórios) em dois pacientes (5,8%). Conclusões: Na dor com característica ciática, contínua ou intermitente e sem evidências de compressão radicular ou herniação discal lombar, deve-se pesquisar a possibilidade de síndrome do piriforme como um diagnóstico eminentemente clínico e de exclusão. O tratamento conservador apresenta resultados satisfatórios na maioria dos casos e a indicação cirúrgica está reservada como último recurso às falhas da terapia conservadora.


Introduction: Piriformis syndrome is a cause of sciatalgy barely understood and frequently unrecognized. It has multiple possible etiologic factors and the treatment of option is largely conservative. Objective: In this retrospective study, the diagnostic signs, the ethiology, the diferential diagnosis and the treatment results are discussed. Methods: 34 patients were followed-up for 6-12 months and evaluated by a simplified symptom rating scale. Results: Excellent results in 23 patients (67,6%), good in 9 patients (26,4%) and fair (unsatisfactory) in 2 patients (5,8%). Conclusions: In patients with sciatic pain without proved rachidian or discal lumbar disease, the possibility of Piriformis Syndrome must be investigated mainly by proper clinical examination and seen as a diagnosis of exclusion. The conservative treatment has satisfactory outcomes in most of cases and surgical procedure is reserved as a last resort in case of failure of the conservative management.


Asunto(s)
Síndrome del Músculo Piriforme , Dolor , Nervio Ciático , Ciática , Síndromes de Compresión Nerviosa
2.
Ann Vasc Surg ; 50: 300.e5-300.e10, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29518516

RESUMEN

BACKGROUND: Transient paraplegia of the lower limbs is a rare condition and, when has a vascular etiology, is usually associated with thromboembolic events, aortic dissection, aortic aneurysms, or as a complication of the surgical correction of those diseases. There is no case reported of acute paraplegia caused by a segmental thrombotic subocclusion of the descending thoracic aorta. CASE REPORT: We report a not yet described clinical situation of a young patient (51 years) admitted to the emergency care department for treatment of systemic arterial hypertension of difficult control with 4 antihypertensive medication classes. At the intensive care unit for treatment with intravenous antihypertensive medication, the patient evolved with acute paraplegia and a segmental thrombotic subocclusion of the descending thoracic aorta was diagnosed. He was submitted to endovascular treatment with total recovery of the deficits. CONCLUSIONS: The previously normal descending thoracic aorta may be a site of segmental thrombosis and may lead to paraplegia. Early endovascular treatment can reverse this type of situation.


Asunto(s)
Aorta Torácica/cirugía , Enfermedades de la Aorta/cirugía , Arteriopatías Oclusivas/cirugía , Implantación de Prótesis Vascular , Procedimientos Endovasculares , Extremidad Inferior/inervación , Paraplejía/etiología , Trombosis/cirugía , Aorta Torácica/diagnóstico por imagen , Aorta Torácica/fisiopatología , Enfermedades de la Aorta/complicaciones , Enfermedades de la Aorta/diagnóstico por imagen , Enfermedades de la Aorta/fisiopatología , Aortografía/métodos , Arteriopatías Oclusivas/complicaciones , Arteriopatías Oclusivas/diagnóstico por imagen , Arteriopatías Oclusivas/fisiopatología , Prótesis Vascular , Implantación de Prótesis Vascular/instrumentación , Angiografía por Tomografía Computarizada , Procedimientos Endovasculares/instrumentación , Humanos , Masculino , Persona de Mediana Edad , Paraplejía/diagnóstico , Paraplejía/fisiopatología , Recuperación de la Función , Trombosis/complicaciones , Trombosis/diagnóstico por imagen , Trombosis/fisiopatología , Resultado del Tratamiento
3.
Ann Vasc Surg ; 28(3): 640-3, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24405772

RESUMEN

BACKGROUND: In patients with peripheral arterial disease, metabolic syndrome is associated with less favorable evolution of intermittent claudication. METHODS: The aims of this study were to determine the prevalence of metabolic syndrome in claudicant patients using the IDF and the NCEP-ATPIII criteria, and to assess the level of agreement between the two definitions. RESULTS: In this cross-sectional study, 200 consecutive patients with intermittent claudication (65% male) were classified with or without metabolic syndrome according both criteria. The kappa coefficient was used to assess the level of agreement. Prevalence of metabolic syndrome was 60.5% when using the NCEP-ATPIII definition and 66.5% when using the IDF definition (P = 0.088). Among men, the prevalence of MetS was 55.4% according to the NCEP-ATPIII and 63.1% according to the IDF (P = 0.110) and, among women, 70.0% according to the NCEP-ATPIII and 72.9% according to the IDF (P = 0.754). CONCLUSION: Although the prevalence rates were similar, the reliability analysis showed that the agreement was substantial only among women and just moderate in the total population and among men.


Asunto(s)
Indicadores de Salud , Claudicación Intermitente/epidemiología , Síndrome Metabólico/diagnóstico , Síndrome Metabólico/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Estudios Transversales , Femenino , Humanos , Claudicación Intermitente/diagnóstico , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Prevalencia , Reproducibilidad de los Resultados , Factores de Riesgo , Factores Sexuales
4.
Arq. bras. cardiol ; 96(4): 325-331, abr. 2011. ilus, tab
Artículo en Portugués | LILACS | ID: lil-585914

RESUMEN

FUNDAMENTO: Insuficiência cardíaca (IC) causada por Doença de Chagas (DC) é uma cardiomiopatia inflamatória progressiva que afeta milhões de pessoas na América Latina. Estudos com modelos de camundongo de IC devido à DC indicam que o transplante de células mononucleares derivadas da medula óssea (TCDMO) pode reduzir a inflamação, fibrose e melhorar a função miocárdica. OBJETIVO: O propósito desse estudo foi avaliar, pela primeira vez em seres humanos, a segurança e a eficácia de TCDMO no miocárdio de pacientes com IC devido à DC. MÉTODOS: Um total de 28 pacientes com IC devido à DC (média de idade de 52,2 ± 9,9 anos) com classe funcional NYHA III e IV foram submetidos à TCDMO através de injeção coronariana. Os efeitos na fração de ejeção do ventrículo esquerdo (FEVE), capacidade funcional, qualidade de vida, arritmias e parâmetros bioquímicos, imunológicos e neuro-humorais foram avaliados. RESULTADOS: Não houve complicações diretamente relacionadas ao procedimento. A FEVE foi 20,1 ± 6,8 por cento e 28,3 ± 7,9 por cento, p < 0,03 a nível basal e 180 dias após o procedimento, respectivamente. No mesmo período, melhoras significantes foram observadas na classe funcional NYHA (3,1 ± 0,3 para 1,8 ± 0,5; p < 0,001), qualidade de vida (50,9 ± 11,7 para 25,1 ± 15,9; p < 0,001), e no teste de caminhada de seis minutos (355 ± 136 m para 437 ± 94 m; p < 0,01). Não houve alterações nos marcadores de ativação imune ou neurohormonais. Nenhuma complicação foi registrada. CONCLUSÃO: Nossos dados sugerem que a injeção intracoronariana de células derivadas da medula óssea é segura e potencialmente efetiva em pacientes com IC devido à DC. A extensão do benefício, entretanto, parece ser discreta e precisa ser confirmada em estudos clínicos maiores, randomizados, duplo-cegos, controlados com placebo.


BACKGROUND: Heart failure due to Chagas' disease (HFCD) is a progressive inflammatory cardiomyopathy that affects millions of individuals in Latin America. Studies using mice models of HFCD indicate that bone marrow mononuclear cell transplantation (BMCT) may reduce inflammation, fibrosis, and improve myocardial function. OBJECTIVE: The purpose of this study was to evaluate, for the first time in humans, the safety and efficacy of BMCT to the myocardium of patients with HFCD. METHODS: A total of 28 HFCD patients (mean age 52.2 ± 9.9 years) with NYHA class III and IV were submitted to BMCT through intracoronary injection. Effects on the left ventricle ejection fraction (LVEF), functional capacity, quality-of-life, arrhythmias, biochemical, immunological, and neuro-humoral parameters, were evaluated. RESULTS: There were no complications directly related to the procedure. LVEF was 20.1 ± 6.8 percent and 28.3 ± 7.9 percent, p < 0.03 at baseline and 180 days after the procedure, respectively. In the same period, significant improvements were observed in the NYHA class (3.1 ± 0.3 to 1.8 ± 0.5; p < 0.001), quality-of-life (50.9 ± 11.7 to 25.1 ± 15.9; p < 0.001), and in the six-minute walking test (355 ± 136 m to 437 ± 94 m; p < 0,01). There were no changes in markers of immune or neurohormonal activation. No complications were registered. CONCLUSION: Our data suggest that the intracoronary injection of BMCT is safe and potentially effective in patients with HFCD. The extent of the benefit, however, appears to be small and needs to be confirmed in a larger randomized, double blind, placebo controlled clinical trial.


FUNDAMENTO: La insuficiencia cardíaca (IC), causada por la enfermedad de Chagas (EC), es una cardiomiopatía inflamatoria progresiva que afecta a millones de personas en Latinoamérica. Estudios con modelos experimentales de IC en razón de la EC, nos indican que el transplante de células mononucleares derivadas de la médula ósea (TCMO), puede reducir la inflamación y la fibrosis, mejorando así la función miocárdica. OBJETIVO:El objetivo de este estudio fue evaluar, por primera vez en seres humanos, la seguridad y la eficacia del TCMO en el miocardio de pacientes con IC debido a la EC. MÉTODOS:Fueron estudiados un total de 28 pacientes con IC debido a la EC (con edad promedio 52,2 ± 9,9 años), en clases funcionales III y IV (NYHA), al TCMO por medio de una inyección coronaria. Se evaluaron los efectos en la fracción de eyección del ventrículo izquierdo (FEVI), capacidad funcional, calidad de vida, arritmias y parámetros bioquímicos, inmunológicos y neurohumorales. RESULTADOS:No se registraron complicaciones relacionadas directamente con el procedimiento. La FEVI pasó de 20,1 ± 6,8 por ciento para 28,3 ± 7,9 por ciento, p < 0,03, cuando se comparó con el período basal y 180 días después del procedimiento, respectivamente. En el mismo período, también se observaron mejorías en la clase funcional NYHA promedio (3,1 ± 0,3 para 1,8 ± 0,5; p < 0,001), puntuación de calidad de vida de Minnesota (50,9 ± 11,7 para 25,1 ± 15,9; p < 0,001), y en el test de esfuerzo de seis minutos (355 ± 136 m para 437 ± 94 m; p < 0,01). No hubo alteraciones en los marcadores de activación inflamatoria o neurohormonales. Ninguna complicación fue registrada. CONCLUSIÓN:Nuestros datos sugieren que la inyección intracoronaria de las células derivadas de la médula ósea es segura y potencialmente efectiva en pacientes con IC debido a la EC. La extensión del beneficio, sin embargo, parece ser discreta, y necesita ser confirmada en los ensayos clínicos randomizados, doble ciegos, controlados con placebo.


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adulto Joven , Trasplante de Médula Ósea , Cardiomiopatía Chagásica/cirugía , Insuficiencia Cardíaca/cirugía , Trasplante de Médula Ósea/efectos adversos , Trasplante de Médula Ósea/inmunología , Cardiomiopatía Chagásica/complicaciones , Fluoroinmunoensayo , Gelatinasas/análisis , Insuficiencia Cardíaca/etiología , Monocinas/análisis , Calidad de Vida , Volumen Sistólico/fisiología , Factores de Tiempo , Resultado del Tratamiento
5.
Arq Bras Cardiol ; 96(4): 325-31, 2011 Apr.
Artículo en Inglés, Portugués, Español | MEDLINE | ID: mdl-21359478

RESUMEN

BACKGROUND: Heart failure due to Chagas' disease (HFCD) is a progressive inflammatory cardiomyopathy that affects millions of individuals in Latin America. Studies using mice models of HFCD indicate that bone marrow mononuclear cell transplantation (BMCT) may reduce inflammation, fibrosis, and improve myocardial function. OBJECTIVE: The purpose of this study was to evaluate, for the first time in humans, the safety and efficacy of BMCT to the myocardium of patients with HFCD. METHODS: A total of 28 HFCD patients (mean age 52.2 ± 9.9 years) with NYHA class III and IV were submitted to BMCT through intracoronary injection. Effects on the left ventricle ejection fraction (LVEF), functional capacity, quality-of-life, arrhythmias, biochemical, immunological, and neuro-humoral parameters, were evaluated. RESULTS: There were no complications directly related to the procedure. LVEF was 20.1 ± 6.8% and 28.3 ± 7.9%, p < 0.03 at baseline and 180 days after the procedure, respectively. In the same period, significant improvements were observed in the NYHA class (3.1 ± 0.3 to 1.8 ± 0.5; p < 0.001), quality-of-life (50.9 ± 11.7 to 25.1 ± 15.9; p < 0.001), and in the six-minute walking test (355 ± 136 m to 437 ± 94 m; p < 0,01). There were no changes in markers of immune or neurohormonal activation. No complications were registered. CONCLUSION: Our data suggest that the intracoronary injection of BMCT is safe and potentially effective in patients with HFCD. The extent of the benefit, however, appears to be small and needs to be confirmed in a larger randomized, double blind, placebo controlled clinical trial.


Asunto(s)
Trasplante de Médula Ósea , Cardiomiopatía Chagásica/cirugía , Insuficiencia Cardíaca/cirugía , Adulto , Anciano , Trasplante de Médula Ósea/efectos adversos , Trasplante de Médula Ósea/inmunología , Cardiomiopatía Chagásica/complicaciones , Femenino , Fluoroinmunoensayo , Gelatinasas/análisis , Insuficiencia Cardíaca/etiología , Humanos , Masculino , Persona de Mediana Edad , Monocinas/análisis , Proyectos Piloto , Calidad de Vida , Volumen Sistólico/fisiología , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
6.
RELAMPA, Rev. Lat.-Am. Marcapasso Arritm ; 23(2): 94-97, abr.-jun. 2010. ilus
Artículo en Inglés | LILACS | ID: lil-559912

RESUMEN

We have abstract documented an unusual simultaneous occurrence of a sinoatrial node reentrant tachycardia and an atrioventricular nodal reentrant tachycardia, interdependent and synchronized between themselves related to a conduction throught an alectrically isolated internodal pathway as a result of capture and entrainment of both circuits, interdependently, which led to a permanent and fixed coupling of both tachycardia cycles and consequent fused atrial beats. Both were ablated. Conclusion: This is a rare case of simultaneous occurrence os both arrhythmias.


Documentamos uma ocorrência simultânea incomum de uma taquicardia reentrante do nó sinoatrial, e uma taquicardia nodal atrioventricular reentrante interdependentes e sincronizadas entre si, relacionadas à uma condução através um modo internodal isolado eletricamente por causa da captura e arrastamento de ambos os circuitos, de forma interdependente, o que levou a um acoplamento fixo e permanente de dois ciclos de taquicardia e a consequentes frequências atriais em fusão. Ambas foram removidas. Conclusão: Este é um caso raro de ocorrência simultânea de ambas as arritmias.


Asunto(s)
Humanos , Femenino , Adulto , Arritmias Cardíacas , Ablación por Catéter/métodos , Taquicardia por Reentrada en el Nodo Sinoatrial , Electrocardiografía
7.
Rev. bras. cardiol. invasiva ; 16(3): 307-311, jul.-set. 2008. tab, graf
Artículo en Portugués | LILACS | ID: lil-503477

RESUMEN

Introdução: Aproximadamente 90 por cento dos pacientes submetidos a cirurgia de revascularização do miocárdio (CRM) recebem enxerto de artéria torácica interna esquerda. A ocorrência de estenose da artéria subclávia esquerda pode resultar em falência do enxerto por limitação de fluxo coronário. A prevalência de estenose da artéia subclávia esquerda em pacientes com aterosclerose coronária grave, considerados candidatos a CRM, não é conhecida. Objetivo: Determinar a prevalência e a eficácia da avaliação clínica para diagnóstico a estenose da artéria subclávia esquerda em candidatos a CRM. Método: Em um registro multicêntrico, realizou-se angiografia seletiva da artéria subclávia esquerda em pacientes com indicação de CRM na ocasião da cinecoronariografia. Estenoses maiores ou iguais a 50 por cento antes da origem da artéria torácica interna foram considerdas significativas. Resultados: Dos 205 pacientes estudados, 16 (7,8 por cento) apresentavam estenose significativa da artéria subclávia esquerda. A medida da pressão arterial não-invasiva diferencial entre...


Background: Approximately 90% of the patients submitted to coronary artery bypass graft surgery (CABG) receive a left internal thoracic artery (LITA) graft. Stenosis of the left subclavian artery can result in graft failure due to restricted coronary flow. The prevalence of stenosis of the left subclavian artery in patients with severe coronary atherosclerosis, deemed candidates to CABG, is not known. Objective: To assess the prevalence of stenosis of left subclavian artery in CABG candidates, as well as the diagnostic effectiveness of clinical evaluation. Methods: In a multicenter registry, selective angiography of the left subclavian artery was carried out in patients considered candidates to CABG during coronary cineangiography. Stenoses ≥ 50% proximal to the origin of the LITA were considered significant. Results: A total of 205 patients were included. Significant stenosis of the left subclavian artery was observed in 16 (7.8%) patients. Noninvasive differential arterial blood pressure measurement ≥ 10 mmHg between both arms showed low sensitivity (37.5%) and low positive predictive value (13.3%) for stenosis identification. No clinical predictors of significant stenosis were identified by univariate analysis. Conclusion: Stenosis of the left subclavian artery is not uncommon in CABG candidates. Noninvasive blood pressure gradient between both arms has low diagnostic accuracy. Therefore, in patients candidates to CABG, selective angiography of the left subclavian artery should be considered, because of the risk of reduced flow and coronary-subclavian steal syndrome in patients with non-diagnosed stenosis of the subclavian artery who receive a LITA graft.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Aterosclerosis/complicaciones , Aterosclerosis/diagnóstico , Constricción Patológica/complicaciones , Constricción Patológica/diagnóstico , Síndrome del Robo de la Subclavia/complicaciones , Síndrome del Robo de la Subclavia/diagnóstico , Angiografía/métodos , Angiografía , Arteria Subclavia/anomalías , Prevalencia
8.
Hum Biol ; 79(4): 453-61, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18075008

RESUMEN

Hyperhomocysteinemia is associated with increased coronary artery disease (CAD) risk. Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme in the metabolism of homocysteine and presents a common mutation (C677T) that leads to a thermolabile enzyme, mild hyperhomocysteinemia, and increased CAD risk. The C677T MTHFR mutation was studied in 772 subjects (480 Caucasian Brazilians and 292 African Brazilians) who underwent coronary angiography at the hemodynamic center of the Santa Izabel Hospital in Salvador, Bahia State, Brazil. The 677T allele frequency was increased in Caucasian Brazilians (28.1%) compared to the frequency observed in African Brazilians (18.3%; p < 0.001). In Caucasian Brazilians the frequency of the 677T homozygous genotype was increased in CAD cases (10.4%) compared to control subjects (1.4%; p = 0.014) in males but not in females. In African Brazilians the mutation was not associated with CAD in either sex. The multivariate logistic regression analysis of all the samples shows that the 677T homozygous interaction with sex was a significant CAD predictor, independent of other classical risk factors and ethnic group. The odds ratio associated with male 677T homozygotes was increased 9.2-fold (p = 0.021) compared to the 677C carriers. The present study suggests that the C677T MTHFR mutation is associated with increased CAD risk in a sex-dependent manner in Brazilians.


Asunto(s)
Angiografía Coronaria , Enfermedad de la Arteria Coronaria/genética , Metilenotetrahidrofolato Reductasa (NADPH2)/genética , Mutación , Adulto , Anciano , Población Negra/genética , Brasil/epidemiología , Estudios de Casos y Controles , Enfermedad de la Arteria Coronaria/epidemiología , Femenino , Genotipo , Humanos , Hiperhomocisteinemia/genética , Masculino , Persona de Mediana Edad , Factores de Riesgo , Factores Sexuales , Población Blanca/genética
9.
Rev. bras. cardiol. invasiva ; 15(4): 443-445, out.-dez. 2007. ilus
Artículo en Portugués | LILACS | ID: lil-477846

RESUMEN

Paciente de 21 anos de idade, com história de dispnéia progressiva aos esforços, fadiga e desconforto torácico leve, mal caracterizado, há aproximadamente um ano, com piora nos últimos trinta dias, quando evoluiu para dispnéia aos mínimos esforços, dispnéia paroxística noturna e ortopnéia. Negava passado de febre reumática e de faringite de repetição. Ecocardiografia transesofágica evidenciou acentuado aneurisma subvalvar em ventrículo esquerdo com regurgitação mitral grave, sem imagens sugestivas de trombo em seu interior. Cineangiocoronariografia realizada a seguir evidenciou estenose dinâmica de até 75% do tronco coronariano esquerdo, artéria descendente anterior em comunicação com estrutura aneurismática trombosada em sua porção inicial e artéria circunflexa com estenose de 75% a 90%, atribuída a compressão extrínseca ocasionada pelo próprio aneurisma subvalvar. Indicado procedimento cirúrgico, negado pela paciente e por seus familiares. A paciente faleceu depois de trinta dias.


A 21-year-old woman with a history of progressive exertion dyspnea, fatigue and mild chest pain lasting 1 year and worsening 1 month before progressing quickly for minimum effort dyspnea, orthopnea and paroxysmal nocturnal dyspnea. She denied past of rheumatic fever and repeated pharyngitis. Transesophageal echocardiogram (ETE) evidenced an important subvalvar aneurysm in the left ventricle with severe mitral regurgitation, without suggestive images of thrombus in its interior. A coronary showed dynamic narrowing of up to 75% of the left main coronary artery (LMCA), the left anterior descending artery (LAD) in communication with aneurysm structure with thrombus in its initial portion and circumflex artery (Cx) with narrowing of 75-90% that was attributed to an extrinsic compression caused by the above mentioned subvalvar aneurysm. A surgical procedure was indicated but was refused, both by the patient and by her family; such refusal evolved into death 30 days after.


Asunto(s)
Humanos , Adulto , Aneurisma Cardíaco , Angioplastia Coronaria con Balón , Insuficiencia de la Válvula Mitral , Vasos Coronarios
10.
Arq. bras. cardiol ; 89(6): 403-408, dez. 2007. graf, tab
Artículo en Inglés, Portugués | LILACS | ID: lil-476075

RESUMEN

FUNDAMENTO: A sedação durante a cineangiocoronariografia tem sido pouco estudada e saber qual é a melhor droga para sedar esses pacientes é um questionamento importante. OBJETIVO: Avaliar a qualidade da sedação e os efeitos sobre a freqüência cardíaca (FC) e a pressão arterial (PA) do midazolam e do diazepam, associados ou não a clonidina, em pacientes com suspeita de doença coronariana. MÉTODOS: Foi desenvolvido ensaio clínico prospectivo, duplo-cego, randomizado, controlado, com 160 pacientes divididos em cinco grupos de 32 pacientes cada, de acordo com o fármaco utilizado: grupo C (clonidina 0,5 µg/kg); grupo M (midazolam 40 µg/kg); grupo MC (associação de midazolam 40 µg/kg e clonidina 0,5 µg/kg); grupo D (diazepam 40 µg.kg); e grupo DC (associação de diazepam 40 µg/kg e clonidina 0,5 µg/kg). A sedação foi avaliada com base na escala de Ramsay e no consumo de meperidina 0,04 mg.kg-1. A PA invasiva, a FC e o escore de sedação foram analisados a cada cinco minutos em quatro diferentes momentos. RESULTADOS: Os pacientes que utilizaram midazolam apresentaram maiores escores de sedação e variação da FC e da PA (p < 0,05). Os que utilizaram diazepam ou clonidina tiveram menores escores de sedação e mais satisfatórios para a realização do exame e apresentaram menor variação da PA e da FC (p > 0,05). CONCLUSÃO: O midazolam foi associado a maior efeito sedativo e cardiovascular enquanto o diazepam causou menor efeito sedativo e cardiovascular. A clonidina e o diazepam tiveram efeitos semelhantes na PA, na FC e na sedação.


BACKGROUND: Sedation during coronary angiography has been rarely studied, and it is important to know which drug is the best to sedate these patients. OBJECTIVE: To evaluate the quality of sedation and the effects of midazolam and diazepam alone or combined with clonidine on the heart rate (HR) and blood pressure (BP) of patients with suspected coronary artery disease. METHODS: This is a controlled, randomized, double-blind, prospective clinical study of 160 patients divided into five groups of 32 patients each, according to the drug used: group C (clonidine 0.5 µg/kg); group M (midazolam 40 µg/kg); group MC (combination of midazolam 40 µg/kg and clonidine 0.5 µg/kg); group D (diazepam 40 µg/kg); and group DC (combination of diazepam 40 µg/kg and clonidine 0.5 µg/kg). Sedation was evaluated based on the Ramsay scale and on the use of meperidine 0.04 mg.kg-1. Invasive BP monitoring, HR and the sedation score were analyzed every five minutes at four different time points. RESULTS: Patients who received midazolam presented higher sedation scores as well as HR and BP variation (p < 0.05). Those who received diazepam or clonidine had lower sedation scores, which were more satisfactory for the performance of the procedure, and presented a lower BP and HR variation (p > 0.05). CONCLUSION: Midazolam was associated with a greater sedative and cardiovascular effect, whereas for diazepam these effects were less intense. Clonidine and diazepam had similar effects on BP, HR and sedation.


Asunto(s)
Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana Edad , Clonidina/farmacología , Sedación Consciente/métodos , Enfermedad Coronaria/diagnóstico , Diazepam/farmacología , Hemodinámica/efectos de los fármacos , Midazolam/farmacología , Análisis de Varianza , Agonistas alfa-Adrenérgicos/farmacología , Presión Sanguínea/efectos de los fármacos , Cineangiografía , Método Doble Ciego , Frecuencia Cardíaca/efectos de los fármacos , Hipnóticos y Sedantes/farmacología , Monitoreo Fisiológico/métodos , Estudios Prospectivos
11.
Clin Chem Lab Med ; 45(7): 874-8, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17617030

RESUMEN

BACKGROUND: Paraoxonases (PON) are members of an enzyme family involved in preventing low-density lipoprotein oxidation and therefore protecting against atherosclerotic plaque formation. METHODS: We studied the Met55Leu and Gln192Arg PON1 polymorphisms in 712 patients (437 Caucasian- and 275 African-Brazilians) who underwent coronary angiography. RESULTS: Among Caucasian-Brazilians, the homozygous 55LeuLeu frequency was higher among patients with significant coronary artery disease (CAD, obstructive lesions >/=50%) than among lesion-free controls (51% vs. 30.3%; p=0.022) in females, but not in males. The Gln192Arg PON1 polymorphism was not associated with CAD, although 192GlnGln homozygotes presented lower high-density lipoprotein (HDL)-cholesterol (p=0.035) and higher triglyceride (p=0.012) levels than 192Arg allele carriers among Caucasian-Brazilian males, but not females. No other lipid-genotype association was detected. Multivariate logistic regression corrected for classic CAD risk factors shows that 55LeuLeu PON1 homozygotes were at increased CAD risk (odds ratio OR=2.852; p=0.003) and that this genotype interacted with gender in its association with CAD risk (OR=0.290; p=0.006) among Caucasian-Brazilians. CONCLUSIONS: This report shows that the 55LeuLeu PON1 genotype increases CAD risk among female Caucasian-Brazilians, irrespective of other CAD risk factors. In addition, 192GlnGln PON1 homozygotes show higher triglyceride and lower HDL-cholesterol levels in male Caucasian-Brazilians. No associations were detected among African-Brazilians.


Asunto(s)
Arildialquilfosfatasa/genética , Enfermedad de la Arteria Coronaria/genética , Polimorfismo Genético , Alelos , Arildialquilfosfatasa/metabolismo , Brasil , HDL-Colesterol/metabolismo , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/enzimología , Enfermedad de la Arteria Coronaria/metabolismo , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Factores de Riesgo , Triglicéridos/metabolismo
12.
Atherosclerosis ; 193(1): 135-41, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16842798

RESUMEN

The nitric oxide produced by endothelial nitric oxide synthase (eNOS) plays a pivotal role in protecting the arterial wall from damages and atherosclerosis. The T-786C, the 27-bp repeat in intron 4, and the E298D eNOS gene polymorphisms were studied in 715 Brazilian patients (447 Caucasian- and 268 African-Brazilians) who underwent coronary angiography. The -786C frequency was increased in coronary artery disease (CAD) cases with significant lesions (> or =50% luminal obstruction) when compared with lesion-free controls; this difference was detected in smokers but not in nonsmokers, both in Caucasian- (p=0.011) and African-Brazilians (p=0.005). The interaction between -786C carriers and smoking was an independent CAD predictor (OR: 2.9, 95% CI: 1.4-5.9; p=0.003) in multiple logistic regression. The 298D mutation frequency was also higher among CAD cases (p=0.036) in African-Brazilian smokers, but this effect was not independent from other variables in the regression model. Though not associated with CAD, the 4-repeat allele combined with different T-786C alleles showed protective and susceptible effects in Caucasian-Brazilian smokers. The -786C/4-repeat/298E haplotype frequency was higher (p=0.020), whereas -786T/4-repeat/298E was lower (p=0.023) in these cases. These results showed a smoking-dependent effect of the T-786C eNOS polymorphism on CAD in both Caucasian- and African-Brazilians. Additionally, the haplotype analysis revealed different eNOS haplotypes associated with protection and susceptibility to the disease.


Asunto(s)
Enfermedad de la Arteria Coronaria/enzimología , Enfermedad de la Arteria Coronaria/genética , Óxido Nítrico Sintasa de Tipo III/genética , Polimorfismo Genético , Adulto , Alelos , Población Negra/genética , Brasil , Estudios de Casos y Controles , Angiografía Coronaria , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/etiología , Femenino , Frecuencia de los Genes , Haplotipos , Heterocigoto , Homocigoto , Humanos , Intrones , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Secuencias Repetitivas de Ácidos Nucleicos , Fumar/efectos adversos , Población Blanca/genética
13.
Arq Bras Cardiol ; 89(6): 403-8, 2007 Dec.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-18317624

RESUMEN

BACKGROUND: Sedation during coronary angiography has been rarely studied, and it is important to know which drug is the best to sedate these patients. OBJECTIVE: To evaluate the quality of sedation and the effects of midazolam and diazepam alone or combined with clonidine on the heart rate (HR) and blood pressure (BP) of patients with suspected coronary artery disease. METHODS: This is a controlled, randomized, double-blind, prospective clinical study of 160 patients divided into five groups of 32 patients each, according to the drug used: group C (clonidine 0.5 microg/kg); group M (midazolam 40 microg/kg); group MC (combination of midazolam 40 microg/kg and clonidine 0.5 microg/kg); group D (diazepam 40 microg/kg); and group DC (combination of diazepam 40 microg/kg and clonidine 0.5 microg/kg). Sedation was evaluated based on the Ramsay scale and on the use of meperidine 0.04 mg.kg-1. Invasive BP monitoring, HR and the sedation score were analyzed every five minutes at four different time points. RESULTS: Patients who received midazolam presented higher sedation scores as well as HR and BP variation (p < 0.05). Those who received diazepam or clonidine had lower sedation scores, which were more satisfactory for the performance of the procedure, and presented a lower BP and HR variation (p > 0.05). CONCLUSION: Midazolam was associated with a greater sedative and cardiovascular effect, whereas for diazepam these effects were less intense. Clonidine and diazepam had similar effects on BP, HR and sedation.


Asunto(s)
Clonidina/farmacología , Sedación Consciente/métodos , Enfermedad Coronaria/diagnóstico , Diazepam/farmacología , Hemodinámica/efectos de los fármacos , Midazolam/farmacología , Adolescente , Agonistas alfa-Adrenérgicos/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Análisis de Varianza , Presión Sanguínea/efectos de los fármacos , Cineangiografía , Método Doble Ciego , Femenino , Frecuencia Cardíaca/efectos de los fármacos , Humanos , Hipnóticos y Sedantes/farmacología , Masculino , Persona de Mediana Edad , Monitoreo Fisiológico/métodos , Estudios Prospectivos
14.
Arq. bras. cardiol ; 87(5): 603-608, nov. 2006. graf, tab
Artículo en Portugués, Inglés | LILACS | ID: lil-439715

RESUMEN

OBJETIVO: Avaliar os efeitos da clonidina sobre a freqüência cardíaca (FC), pressão arterial (PA) e sedação de pacientes submetidos à cineangiocoronariografia. MÉTODOS: Um ensaio clínico prospectivo, duplo cego, randomizado, controlado, foi realizado com 62 pacientes submetidos a cineangiocoronariografias eletivas, divididos em dois grupos: grupo clonidina que utilizou 0,8 æg/kg desta droga, e o grupo controle que utilizou solução fisiológica a 0,9 por cento. A sedação foi avaliada com base na escala de Ramsay e o consumo de meperidina 0,04 mg/kg que foi utilizada nos pacientes que apresentaram agitação ou ansiedade durante o procedimento. A PA invasiva, a FC e o escore de sedação, de acordo com a escala de Ramsay, foram analisados a cada 5 minutos e quatro diferentes momentos foram considerados para avaliação: M1- inicio do exame; M2- 5 minutos após o início do exame; M3- mediana do tempo do exame e M4 - final do exame. RESULTADOS: O grupo clonidina apresentou maior estabilidade da PA e FC e eficácia na sedação, enquanto o grupo controle apresentou um maior consumo de meperidina (p<0,05). Na análise estatística, para inferência das variáveis contínuas foi utilizado o teste T ou Mann-Whitney e chi2 ou Teste Exato de Fisher para as variáveis categóricas. CONCLUSÃO: Este trabalho mostrou que, nos pacientes submetidos à cineangiocoronariografia, a utilização da clonidina foi eficaz tanto no controle da PA e FC quanto em proporcionar uma sedação consciente.


OBJECTIVE: To evaluate the effects of clonidine on heart rate (HR), and blood pressure (BP) as well as its sedative effect on patients submitted to a cineangiocardiography. METHODS: A randomized, controlled, double blind, prospective clinical trial was conducted on 62 patients submitted to an elective cineangiocardiography. The patients were divided in two groups: the clonidine group, that were administered a 0.8 æg/kg dose of this drug and the control group, that were administered a 0.9 percent saline solution. Sedation was evaluated based on the Ramsay Scale and the administration of a 0.04 mg/kg dose of meperidine that was given to the patients who were agitated or anxious during the procedure. The invasive BP, HR and sedation score based on the Ramsay Scale were analyzed every 5 minutes and four different intervals were considered for the assessment: I1- start of the test; I2- 5 minutes after the start of the test; I3- median time of the test and I4- end of the test. RESULTS: The clonidine group presented better BP and HR stability and sedation efficacy while the control group presented a higher intake of meperidine (p<0.05). In the statistical analysis, the inference of the continuous variables was calculated using the Student's t-test or Mann-Whitney test and the chi2 or Fisher Exact Probability test was used for the categorical variables. CONCLUSION: This study demonstrated that clonidine was an efficient means to control BP and HR and provided a conscious sedation for patients submitted to a cineangiocardiography.


Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anciano de 80 o más Años , Agonistas alfa-Adrenérgicos/uso terapéutico , Presión Sanguínea/efectos de los fármacos , Clonidina/uso terapéutico , Angiografía Coronaria/métodos , Frecuencia Cardíaca/efectos de los fármacos , Hipnóticos y Sedantes/uso terapéutico , Agonistas alfa-Adrenérgicos/farmacología , Cineangiografía , Clonidina/farmacología , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Hipnóticos y Sedantes/farmacología , Meperidina/administración & dosificación , Estudios Prospectivos
15.
Arq Bras Cardiol ; 87(2): 159-66, 2006 Aug.
Artículo en Portugués | MEDLINE | ID: mdl-16951834

RESUMEN

OBJECTIVE: To evaluate early effects of bone marrow cell transplantation to the myocardium of patients with heart failure (CHF) due to Chagas disease. METHODS: We studied 28 patients (mean age 52.2 +/- 9.9), of whom 24 were male. Despite optimized treatment, 25 patients were in NYHA class III and three patients, in NYHA class IV. The procedure consisted of aspiration of 50 mL of bone marrow, separation of the mononuclear fraction, and intracoronary injection. Effects on left ventricle ejection fraction (LVEF), distance walked in the six-minute walking test, quality-of-life, NYHA class, arrhythmogenic and biochemical parameters, were all evaluated. RESULTS: There were no complications directly related to the procedure. Baseline left ventricular ejection fraction was 20.1 +/- 6.8%, and 60 days after transplantation it increased to 23.0 +/- 9.0%, p = 0.02. Significant improvements were observed in the NYHA class (3.1 +/- 0.3 to 1.8 +/- 0.5; p < 0.0001); quality-of-life (50.9 +/- 11.7 to 21.8 +/- 13.4; p < 0.0001); and distance walked in six minutes (355 +/- 136 m to 443 +/- 110 m; p = 0,003). The number of ventricular premature beats in 24 hours tended to increase (5,322 +/- 4,977 to 7,441 +/- 7,955; p = 0,062), but without increase in ventricular tachycardia episodes (61 +/- 127 to 54 +/- 127; p = 0.27). CONCLUSION: Our data demonstrate for the first time that intracoronary injection of bone marrow mononuclear cells is feasible and suggest that it may be potentially safe and effective in patients with CHF due to Chagas disease.


Asunto(s)
Trasplante de Médula Ósea/normas , Gasto Cardíaco Bajo/cirugía , Cardiomiopatía Chagásica/cirugía , Adulto , Anciano , Gasto Cardíaco Bajo/etiología , Cardiomiopatía Chagásica/complicaciones , Enfermedad Crónica , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Sodio/análisis , Trasplante de Células Madre/normas , Células Madre/citología , Resultado del Tratamiento
16.
Arq. bras. cardiol ; 87(2): 159-166, ago. 2006. tab, graf
Artículo en Portugués | LILACS | ID: lil-434003

RESUMEN

OBJETIVO: Avaliar efeitos precoces do transplante de células de medula óssea para o miocárdio de pacientes com insuficiência cardíaca (IC) de etiologia chagásica. MÉTODOS: A amostra consistiu de 28 pacientes, idade média 52,2±9,9 anos, 24 masculinos, 25 em classe NYHA III e 3 em NYHA IV, apesar de tratamento otimizado. O procedimento consistiu na aspiração de 50ml de medula óssea, separação da fração mononuclear e injeção intracoronariana. Foram avaliados os efeitos sobre a fração de ejeção ventricular esquerda (FEVE), distância no teste de 6 minutos, qualidade de vida, classe NYHA, efeitos arritmogênicos e bioquímicos. RESULTADOS: Não houve complicações relacionadas diretamente ao procedimento. A fração de ejeção ventricular esquerda em repouso antes do transplante era 20,1±6,8 por cento e, após 60 dias, aumentou para 23,0±9,0 por cento, p = 0,02. Houve melhora da classe NYHA (3,1±0,3 para 1,8±0,5; p<0.0001); qualidade de vida (50,9±11,7 para 21,8±13,4; p<0.0001); distância caminhada (355±136 m para 443±110 m; p = 0,003). O número de extrassístoles ventriculares em 24h apresentou tendência à elevação (5.322±4.977 para 7.441±7.955; p = 0,062), porém sem incremento dos episódios de taquicardia ventricular (61±127 para 54±127; p = 0,27). CONCLUSÃO: Nossos dados demonstram que a injeção intracoro¡nariana de células mononucleares da medula óssea é exeqüível e sugere ser potencialmente segura e eficaz em pacientes com IC de etiologia chagásica.


Asunto(s)
Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trasplante de Médula Ósea/normas , Gasto Cardíaco Bajo/cirugía , Cardiomiopatía Chagásica/cirugía , Enfermedad Crónica , Gasto Cardíaco Bajo/etiología , Cardiomiopatía Chagásica/complicaciones , Estudios de Seguimiento , Sodio/análisis , Trasplante de Células Madre/normas , Células Madre/citología , Resultado del Tratamiento
17.
Arq Bras Cardiol ; 87(5): 603-8, 2006 Nov.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-17221036

RESUMEN

OBJECTIVE: To evaluate the effects of clonidine on heart rate (HR), and blood pressure (BP) as well as its sedative effect on patients submitted to a cineangiocardiography. METHODS: A randomized, controlled, double blind, prospective clinical trial was conducted on 62 patients submitted to an elective cineangiocardiography. The patients were divided in two groups: the clonidine group, that were administered a 0.8 microg/kg dose of this drug and the control group, that were administered a 0.9% saline solution. Sedation was evaluated based on the Ramsay Scale and the administration of a 0.04 mg/kg dose of meperidine that was given to the patients who were agitated or anxious during the procedure. The invasive BP, HR and sedation score based on the Ramsay Scale were analyzed every 5 minutes and four different intervals were considered for the assessment: I1- start of the test; I2- 5 minutes after the start of the test; I3- median time of the test and I4- end of the test. RESULTS: The clonidine group presented better BP and HR stability and sedation efficacy while the control group presented a higher intake of meperidine (p<0.05). In the statistical analysis, the inference of the continuous variables was calculated using the Student's t-test or Mann-Whitney test and the chi2 or Fisher Exact Probability test was used for the categorical variables. CONCLUSION: This study demonstrated that clonidine was an efficient means to control BP and HR and provided a conscious sedation for patients submitted to a cineangiocardiography.


Asunto(s)
Agonistas alfa-Adrenérgicos/uso terapéutico , Presión Sanguínea/efectos de los fármacos , Clonidina/uso terapéutico , Angiografía Coronaria/métodos , Frecuencia Cardíaca/efectos de los fármacos , Hipnóticos y Sedantes/uso terapéutico , Adolescente , Agonistas alfa-Adrenérgicos/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Cineangiografía , Clonidina/farmacología , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Femenino , Humanos , Hipnóticos y Sedantes/farmacología , Masculino , Meperidina/administración & dosificación , Persona de Mediana Edad , Estudios Prospectivos
18.
Arq Bras Cardiol ; 82(2): 185-7, 181-4, 2004 Feb.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-15042255

RESUMEN

We report the first case of bone marrow cell transplantation to the myocardium of a patient with heart failure due to chagas' disease. The patient is a 52-year-old man with chronic heart failure, NYHA functional class III, despite the optimized clinical therapy. The procedure consisted of aspiration of 50 mL of bone marrow through puncture of the iliac crest, followed by filtration, separation of the mononuclear cells, resuspension, and intracoronary injection. The left ventricular ejection fraction at rest, measured using radionuclide ventriculography with labeled red blood cells prior to transplantation, was 24%, and, after 30 days, it increased to 32% with no change in the medicamentous schedule. The following measurements were assessed before and 30 days after transplantation: left ventricular end diastolic diameter (82 mm and 76 mm, respectively); Minnesota living with heart failure questionaire score (55 and 06, respectively); and distance walked in the 6-minute walking test (513 m and 683 m, respectively). Our findings show that intracoronary injection of bone marrow cells may be performed, suggesting that this is a potentially safe and effective procedure in patients with due to Chagas' disease heart failure.


Asunto(s)
Trasplante de Médula Ósea , Gasto Cardíaco Bajo/cirugía , Cardiomiopatía Chagásica/cirugía , Miocardio , Gasto Cardíaco Bajo/etiología , Cardiomiopatía Chagásica/complicaciones , Enfermedad Crónica , Humanos , Masculino , Persona de Mediana Edad
19.
Arq. bras. cardiol ; 82(2): 181-187, fev. 2004. ilus, tab
Artículo en Inglés, Portugués | LILACS | ID: lil-356082

RESUMEN

Apresentado o primeiro caso de transplante de célula de medula óssea para o miocárdio de um portador de insuficiência cardíaca de etiologia chagásica. Homem, 52 anos, portador de insuficiência cardíaca crônica, em classe funcional III da NYHA, apesar de terapêutica clínica otimizada. Como procedimento, foi aspirado 50 ml de medula óssea através de punção da crista ilíaca, seguidos de filtragem, separação das células mononucleares, ressuspensão e injeção intracoronariana. A fração de ejeção do ventrículo esquerdo em repouso, medida pela ventriculografia radioisotópica com hemácias marcadas, antes do transplante, era de 24 por cento e, após 30 dias, aumentou para 32 por cento sem alterar o esquema medicamentoso. Foram avaliados, antes e 30 dias após o procedimento, respectivamente, o diâmetro diastólico final do ventrículo esquerdo (82 mm; 76 mm); escore de qualidade de vida de Minnesota (55; 06); distância caminhada no teste de 6min (513 m; 683 m). Achados demonstraram ser possível realizar a injeção intracoronariana de célula de medula óssea, sugerindo que este procedimento é potencialmente seguro e efetivo em pacientes com insuficiência cardíaca chagásica.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Trasplante de Médula Ósea , Gasto Cardíaco Bajo/etiología , Cardiomiopatía Chagásica/complicaciones , Miocardio/citología , Enfermedad Crónica , Gasto Cardíaco Bajo/cirugía , Cardiomiopatía Chagásica/cirugía
20.
REBLAMPA Rev. bras. latinoam. marcapasso arritmia ; 16(1): 23-30, Jan-Mar. 2003. ilus, graf
Artículo en Portugués | LILACS | ID: lil-407500

RESUMEN

O bloqueio atrioventricular de primeiro grau pode não ser tão benigno. Há pacientes que necessitam de implante de marcapasso dupla-câmara para ressincronizar as contrações atrial e ventricular e dessa maneira aliviar sintomas decorrentes da simultaneidade entre ambas contraçoes, que pode ocorrer durante o esforço físico. Nesses casos a indicação do marcapasso objetiva melhorar a qualidade de vida do paciente, tal como exemplifica o caso descrito


Asunto(s)
Humanos , Femenino , Anciano , Bloqueo Cardíaco/fisiopatología , Estimulación Cardíaca Artificial , Marcapaso Artificial , Ansiedad , Mareo , Fatiga , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA